BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1057642)

  • 1. Effect of N6-(delta2-isopentenyl)adenosine treatment in vivo on hexokinase activity of mouse L 1210 cells.
    Shavelson LJ; Tritsch GL
    J Med; 1975; 6(2):181-8. PubMed ID: 1057642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural occurrence of an inhibitor of mammalian cell growth in human and mouse cells of normal and tumor origin.
    Burns DM; Rodi CP; Agris PF
    Cancer Biochem Biophys; 1976; 1(6):269-80. PubMed ID: 1035127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of natural resistance to N6-(delta2-isopentenyl)adenosine in cultured cells.
    Slocum HK; Hakala MT
    Cancer Res; 1975 Feb; 35(2):423-8. PubMed ID: 162874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of hexokinase insoenzyme pattern in Ehrlich ascites-tumor cells in relation to the utilization of glucose in the cells.
    Murakami K; Ishibashi S
    J Biochem; 1973 Feb; 73(2):207-15. PubMed ID: 4145404
    [No Abstract]   [Full Text] [Related]  

  • 5. N6-(delta2-isopentenyl)adenosine, an inhibitor of cellular transport of uridine and cytidine.
    Hakala MT; Slocum HK; Gryko GJ
    J Cell Physiol; 1975 Oct; 86(2 Pt 1):281-91. PubMed ID: 1194366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic adenosine 3':5'-monophosphate-dependent protein phosphorylation and the control of leukemia L1210 cell growth.
    Mednieks MI; Jungmann RA; DeWys WD
    Cancer Res; 1982 Jul; 42(7):2742-7. PubMed ID: 6282449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cytotoxicity of N6-(delta 2-isopentenyl)adenosine in combination with pentostatin against L-1210 leukemia cells.
    Hacker B; Chang Y
    J Pharm Sci; 1983 Oct; 72(10):1225-6. PubMed ID: 6606032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residues putatively involved in binding of ATP and glucose 6-phosphate to a mammalian hexokinase: site-directed mutation at analogous positions in the N- and C-terminal halves of the type I isozyme.
    Baijal M; Wilson JE
    Arch Biochem Biophys; 1995 Aug; 321(2):413-20. PubMed ID: 7646067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineoplastic effects of N6-(delta 2-isopentenyl)adenosine against L-1210 mouse lymphocytic leukemic cells using a polymeric delivery system.
    Chang Y; Hacker B
    J Pharm Sci; 1982 Mar; 71(3):328-31. PubMed ID: 7069592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria, hexokinase and pyruvate kinase isozymes in the aerobic glycolysis of tumor cells.
    Petrucci D; Cesare P; Colafarina S
    Ital J Biochem; 1997 Sep; 46(3):131-41. PubMed ID: 9442422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of hexokinases I and II of ELD cells by binding to mitochondria.
    Okazaki H; Imai N; Nagamura H; Ishibashi S
    Biochem Int; 1989 Jan; 18(1):211-6. PubMed ID: 2719712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the properties of hexokinase from hyaloplasm on binding with mitochondria].
    Shcherbatykh LN; Goncharova NIu; Aleksakhina NV
    Biokhimiia; 1977 Aug; 42(8):1408-18. PubMed ID: 911936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the antitumor activity of N6-(delta 2-isopentenyl)adenosine against cultured L-1210 leukemia cells by pentostatin using a polymeric delivery system.
    Hacker B; Chang Y
    J Pharm Sci; 1983 Aug; 72(8):902-5. PubMed ID: 6604803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of insulin on the catalytic efficacy of rat skeletal muscle hexokinase isoenzyme II].
    Goncharova NIu; Zelenina EV
    Biokhimiia; 1991 May; 56(5):913-22. PubMed ID: 1747417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexose-specificity of hexokinase and ADP-dependence of pyruvate kinase play important roles in the control of monosaccharide utilization in freshly diluted boar spermatozoa.
    Medrano A; García-Gil N; Ramió L; Montserrat Rivera M; Fernández-Novell JM; Ramírez A; Peña A; Dolors Briz M; Pinart E; Concha II; Bonet S; Rigau T; Rodríguez-Gil JE
    Mol Reprod Dev; 2006 Sep; 73(9):1179-94. PubMed ID: 16804879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Km glucose-phosphorylating (glucokinase) activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptulose.
    Board M; Colquhoun A; Newsholme EA
    Cancer Res; 1995 Aug; 55(15):3278-85. PubMed ID: 7614462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of cAMP on hexokinase and glucose-6-phosphate dehydrogenase isoenzymes in different white rat tissues].
    Panin LE; Russkikh GS; Voĭtsekhovskaia EE
    Biull Eksp Biol Med; 1981 Jul; 92(7):52-4. PubMed ID: 6271287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plant science. Hexokinase, Jack-of-all-trades.
    Frommer WB; Schulze WX; Lalonde S
    Science; 2003 Apr; 300(5617):261-3. PubMed ID: 12690178
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose utilization during gonadotropin-induced meiotic maturation in cumulus cell-enclosed mouse oocytes.
    Downs SM; Humpherson PG; Martin KL; Leese HJ
    Mol Reprod Dev; 1996 May; 44(1):121-31. PubMed ID: 8722700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified form of mitochondrial hexokinase produced by ATP-induced solubilization.
    Ureta T; Radojković J; Bustamante E
    Biochem Int; 1983 Nov; 7(5):585-92. PubMed ID: 6679748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.